D - Description
|
Quality
Management |
Training and
Education |
Public
Involvement |
| Description | |
|---|---|
Name |
CEPOETA - Central European Pediatric Oncology Early Trials Alliance |
| Year of foundation | 2015 |
| Preterm and/or term newborn | Yes |
| Infants from 1 month to less than 24 months of age | Yes |
| Children from 2 years to less than 12 years of age | Yes |
| Adolescents from 12 years to less than 18 years | Yes |
| Paediatric age ranges of study participants covered by the network | 0-18 years, young adults |
| Multispeciality? Specify | Oncology, hematooncology, hematology, supportive care |
| Speciality/disease specific? Specify | ncology, hematooncology, hematology, supportive care |
| Conditions covered? Specify | Malignant solid tumours, liquid lymphomas, genetics and immunology |
| Procedure/Intervention specific? Specify | The multidisciplinary anticancer treatment and treatment of blood disorders, surgery, autologous stem cell transplantation |
| Number of collaborating countries | 8 |
| List of collaborating countries | Czech Republic, Slovakia, Poland, Hungary, Slovenia, Macedonia, Bulgaria, Serbia |
| Number of collaborating centres | 12 |
| List of collaborating centres | University hospital st. Anne´s Brno, ICRC; University hospital Brno; University hospital Motol; Masaryk Memorial Cancer Institute; 2nd Department of Pediatrics, Semmelweis University; Department of Pediatric Hematology-Oncology, University of Debrecen; Hematology and Oncology, University Children's Hospital, Skopje, Macedonia; Medical school University of Belgrade, University Children`s Hospital; Medical Faculty, University Ljubljana; Department of Pediatric Hematology and Oncology Comenius University in Bratislava; Hematology, HSCT Unit, Specialized Children's Oncohaematology Hospital Sofia; Department of Pediatric Hematology and Oncology, Medical University of Silesia in Katowice |
| Type of activity/studies | Clinical Triala phase I/II-IV, Investigator-initiated trials, registry, observational studies |
| Clinical Studies | Yes |
| Experimental research | Yes |
| Other activity | Participation in BFM, SIOP, COG protocols, cooperation with the parents abd patients organisation in the region, activities to increasing public awareness of pediatric oncology |